David P. Rosenbaum - 08 Oct 2021 Form 4 Insider Report for ARDELYX, INC. (ARDX)

Role
Chief Development Officer
Signature
/s/ Elizabeth Grammer, Attorney-in-Fact for David Rosenbaum
Issuer symbol
ARDX
Transactions as of
08 Oct 2021
Net transactions value
$0
Form type
4
Filing time
29 Oct 2021, 19:57:17 UTC
Previous filing
24 Aug 2021
Next filing
24 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARDX Common Stock Award $0 +150,000 +93% $0.000000 311,804 08 Oct 2021 Direct F1, F2
transaction ARDX Common Stock Award $0 +60,000 +195% $0.000000 90,811 08 Oct 2021 By Wife F1, F2, F3, F4
holding ARDX Common Stock 77,592 08 Oct 2021 Family Trust F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.
F2 Reflects the adjusted total which includes the purchase of 3,000 shares under the Ardelyx Employee Stock Purchase Plan on February 28, 2021.
F3 Reflects the adjusted total which includes the purchase of 1,237 shares under the Ardelyx Employee Stock Purchase Plan on August 31, 2021.
F4 The shares are directly held by the Reporting Person's wife.
F5 The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.